Asia
Luminescing nanosized crystals are showing promise for peering deeply into body tissues, but first they need to be made safe.
There has been significant progress in so-called bioprinting—using a type of 3D printing to manufacture biological tissues. But an actual organ hadn’t been accomplished—until now.
Insilico Biotechnology AG announces the opening of a representation in Singapore to develop its business in the Asia-Pacific (APAC) region and to strengthen support for its growing customer base.
TLC announced the successful completion of its End-of-Phase II meeting with the U.S. Food and Drug Administration (FDA) on receiving guidance, and discussing the clinical and regulatory pathway for a potential U.S. approval of TLC599, a BioSeizer® liposomal formulation of dexamethasone sodium phosphate for the treatment of knee osteoarthritis.
Stephen Quake, a Stanford University bioengineer and inventor, recently shared several years’ worth of email communications between himself and He with The New York Times.
Biopharma companies tap new hires to assume roles in leadership positions, with additions at Metrion, JDRF, Ribometrix, and more.
Pharma and biotech companies from Asia to Europe provide updates on business and clinical activities.
The distinct roles of these immune cells opens the possibility of new treatments for human inflammatory diseases
Bionovate Technologies, Corp. announced that during the last fiscal year’s reporting period, it acquired a patent from Ramot University in Tel Aviv, Israel as part of the company’s strategy to develop non-invasive cancer imaging and identification systems.
Eisai Co., Ltd. has announced that its in-house discovered fibroblast growth factor receptor tyrosine kinase inhibitor E7090 has been granted the SAKIGAKE designation by Japan’s Ministry of Health, Labour and Welfare for the treatment of unresectable biliary tract cancer with FGFR2 gene fusion.
PRESS RELEASES